Nissan Medical Industries Ltd (TLV:NISA)
Israel · Delayed Price · Currency is ILS · Price in ILA 900.70
+1.40 (0.16%)
Sep 2, 2026, 5:24 PM IDT
Nissan Medical Industries Financials Overview
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 607.36 | 651.78 | 664.08 | 733.91 | 684.65 | 668.37 |
Revenue Growth | -3.28% | -1.85% | -9.52% | 7.20% | 2.44% | -7.36% |
Gross Profit Gross Profit Growth | 92.03 | 88.37 | 98.02 | 135.78 | 83.28 | 144.42 |
Operating Income Operating Income Growth | 27.86 | 25.78 | 29.68 | 61.37 | -1.77 | 65.81 |
Net Income Net Income Growth | 7.27 | 4.17 | 7.91 | 5.65 | -36.05 | 36.01 |
Earnings Per Share EPS Growth | 0.76 | 0.46 | 0.87 | 0.62 | -3.97 | 3.93 |
EPS Growth | - | -47.20% | 39.90% | - | - | -37.13% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
USA and Canada USA and Canada Growth | 527.17 | 537.54 | 607.76 | 508.64 | 544.44 |
Europe Europe Growth | 45.03 | 45.93 | 50.79 | 54.56 | 63.26 |
The Rest of America The Rest of America Growth | 45.06 | 55.32 | 47.97 | 69.95 | 49.64 |
Others Others Growth | 34.52 | 25.28 | 27.4 | 51.5 | 11.04 |
Total Total Growth | 651.78 | 664.08 | 733.91 | 684.65 | 668.37 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 14.2 | 17.7 | 17.29 | 25.05 | 19.51 | 40.16 |
Total Debt Total Debt Growth | 178.94 | 189.76 | 202.5 | 198.26 | 251.08 | 240.84 |
Net Cash (Debt) Net Cash Growth | -164.74 | -172.06 | -185.21 | -173.21 | -231.57 | -200.69 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -17.28 | -18.94 | -20.39 | -19.07 | -25.49 | -22.09 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 63.54 | 62.64 | 26.83 | 105.72 | 11.67 | 17.98 |
Capital Expenditures CapEx Growth | -31.95 | -26.11 | -6.09 | -9.82 | -9.18 | -8.16 |
Free Cash Flow Free Cash Flow Growth | 31.6 | 36.53 | 20.74 | 95.9 | 2.49 | 9.82 |
Free Cash Flow Growth | 25.42% | 76.09% | -78.37% | 3745.07% | -74.60% | -90.97% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 15.15% | 13.56% | 14.76% | 18.50% | 12.16% | 21.61% |
Operating Margin | 4.59% | 3.96% | 4.47% | 8.36% | -0.26% | 9.85% |
Pretax Margin | 2.78% | 1.54% | 2.28% | 3.79% | -6.87% | 10.54% |
Profit Margin | 1.20% | 0.64% | 1.19% | 0.77% | -5.27% | 5.39% |
FCF Margin | 5.20% | 5.60% | 3.12% | 13.07% | 0.36% | 1.47% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.820 | 1.820 | 0.750 | - | - | 0.440 |
Dividend Per Share Growth | 0% | 142.67% | - | - | - | -56.00% |
Dividend Yield | 21.98% | 19.84% | 6.96% | - | - | 2.55% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.81 | 19.97 | 14.66 | 17.37 | - | 5.53 |
P/FCF Ratio | 2.59 | 2.28 | 5.59 | 1.02 | 31.30 | 20.27 |
PS Ratio | 0.13 | 0.13 | 0.18 | 0.13 | 0.11 | 0.30 |